Codiak BioSciences, Inc. Proceeds from Stock Options Exercised
Codiak BioSciences, Inc. reported Proceeds from Stock Options Exercised of $3.74 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2022-11-03
- Codiak BioSciences, Inc. proceeds from stock options exercised for the quarter ending 2021-12-31 was $215.00K, a 138.89% increase year-over-year.
- Codiak BioSciences, Inc. proceeds from stock options exercised for the quarter ending 2021-09-30 was $753.00K, a 1881.58% increase year-over-year.
- Codiak BioSciences, Inc. proceeds from stock options exercised for the quarter ending 2021-06-30 was $2.45M, a 2753.49% increase year-over-year.
- Codiak BioSciences, Inc. proceeds from stock options exercised for the quarter ending 2021-03-31 was $316.00K, a 1655.56% increase year-over-year.
- Codiak BioSciences, Inc. proceeds from stock options exercised for fiscal 2021 was $3.74M, a 1511.21% increase from fiscal 2020.
- Codiak BioSciences, Inc. proceeds from stock options exercised for fiscal 2020 was $232.00K, a 10.42% decline from fiscal 2019.
- Codiak BioSciences, Inc. proceeds from stock options exercised for fiscal 2019 was $259.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2021-12-31 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $968.00K derived: sum of 2 quarters · filed 2022-11-03 | $3.42M derived: sum of 3 quarters · filed 2022-11-03 | $3.74M 10-K · filed 2022-03-10 |
| 2021-09-30 | $753.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $3.21M derived: sum of 2 quarters · filed 2022-11-03 | $3.52M 10-Q · filed 2022-11-03 | $3.61M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $2.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $2.77M 10-Q · filed 2022-08-04 | $2.86M derived: sum of 3 quarters · filed 2022-08-04 | $2.90M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $316.00K 10-Q · filed 2022-05-05 | $406.00K derived: sum of 2 quarters · filed 2022-05-05 | $444.00K derived: sum of 3 quarters · filed 2022-05-05 | $530.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $128.00K derived: sum of 2 quarters · filed 2022-03-10 | $214.00K derived: sum of 3 quarters · filed 2022-03-10 | $232.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $124.00K derived: sum of 2 quarters · filed 2021-11-04 | $142.00K 10-Q · filed 2021-11-04 | $147.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $104.00K 10-Q · filed 2021-08-05 | $109.00K derived: sum of 3 quarters · filed 2021-08-05 | |
| 2020-03-31 | $18.00K 10-Q · filed 2021-05-06 | $23.00K derived: sum of 2 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $259.00K 10-K · filed 2021-03-17 | ||
| 2019-09-30 | $254.00K 10-Q · filed 2020-11-19 |